Searched for
FRONT END PHARMACEUTICAL SALES
API prices fall as West Asia tensions ease, boosting Indian pharma sectorPrices for active pharmaceutical ingredients have seen a decline of five to ten percent, thanks to the calming geopolitical climate in West...
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...
Diksha Polymers IPO opens today. Check GMP, subscription, and other detailsThe allotment is expected to be finalised on June 22, while the shares are scheduled to list on the BSE SME platform on June 24.
Leapfrog Engineering Services IPO: Check GMP, price band, subscription and other detailsThe IPO comprises a fresh issue of 3.46 crore shares aggregating Rs 79.6 crore and an offer for sale of 38.76 lakh shares worth Rs 8.91 cro...
US set to offer Iran $300 billion development fund, broad financial gains in peace dealIran is poised to receive significant financial incentives, including immediate oil sales and access to a $300 billion development fund, as...
Retail players can skip GIC Re's OFS: AnalystsRetail investors are advised to skip the government's offer for sale in General Insurance Corp of India. Analysts point to ongoing profitab...
Government prescribes end to over-the-counter sale of cough syrupsEven in small villages with a population of less than 1,000, where certain remedies including cough syrups were allowed to be sold without ...
Kiran Mazumdar-Shaw eyes crown of world’s top insulin supplier for BioconIndian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...
Iran FM says ending war including in Lebanon 'most important issue' in US dealIran's Foreign Minister Abbas Araghchi said on Tuesday that ending the war on all fronts, including Lebanon, was "the most important" issue...
Govt ends over-the-counter sales of all 'syrups'; mandates doctor's prescription for purchaseThe Union Ministry of Health and Family Welfare has mandated that all syrups, including cough syrups, are now prescription-only. This new r...
Leapfrog Engineering Services IPO to open on Wed at Rs 21-23 per shareLeapfrog Engineering Services Ltd has set its IPO price band at Rs 21-23 per share, opening for subscription on June 17, 2026. The Rs 88.51...
Iran says agreement with US immediately ends warIran said that the newly announced agreement with the United States put an "immediate end" to the countries' war. "A permanent and immediat...
IPO Calendar: Two companies to launch public offers in a quiet week for the primary marketThe IPO market will see limited activity next week, with only two SME issues, Liotech Industries and Leapfrog Engineering, opening on June ...
Women's cricket showpiece can co-exist with football World Cup, says ICC chiefThe Women's T20 World Cup is set to be a major sporting event. ICC chief executive Sanjog Gupta believes it can thrive alongside the men's ...
Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 26%On Thursday evening, US President Trump said he would “hit Iran hard tonight”. Then, as the world waited with bated breath, came the announ...
These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
India bonds end higher as oil eases; focus shifts to debt sale, inflationThursday marked a positive performance for Indian government bonds, buoyed by falling oil prices that alleviated fears tied to the U.S.-Ira...
India's weight-loss market grows upThe landscape of India's anti-obesity drug market has reached a point of refinement. While there are affordable generic options, their upta...
Govt outlines next phase of pharma growthThe government highlighted its achievements, reforms, and policy initiatives, aiming to boost exports from $31 billion to $50 billion by 20...
PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stakePrivate equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per sha...